PainReform News

Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ), PainReform (PRFX) and IN8bio (INAB)

TipRanksApr 10 12:50 ET

Buy Rating Affirmed for PainReform as PRF-110 Shows Promise in Non-Opioid Pain Management Market

TipRanksApr 3 11:15 ET

Buy Rating for PainReform's PRF-110: Promising Non-Opioid Pain Solution Amidst Opioid Crisis

TipRanksMar 5 13:25 ET

Buy Rating for PainReform's PRF-110: Superior Spreadability Signaling Market Advantage

TipRanksJan 4 11:25 ET

Analysts Offer Insights on Healthcare Companies: PainReform (PRFX) and Tenet Healthcare (THC)

TipRanksNov 17, 2023 12:11 ET

PainReform (PRFX) Gets a Buy From Maxim Group

TipRanksSep 12, 2023 14:15 ET

Maxim Group Remains a Buy on PainReform (PRFX)

TipRanksAug 12, 2023 10:25 ET

Analysts Offer Insights on Healthcare Companies: Ascendis Pharma (ASND), EDAP TMS (EDAP) and PainReform (PRFX)

TipRanksMay 18, 2023 11:50 ET

Maxim Group Reaffirms Their Buy Rating on PainReform (PRFX)

TipRanksMay 2, 2023 10:53 ET

Analysts Are Bullish on These Healthcare Stocks: Aravive (ARAV), PainReform (PRFX)

TipRanksMar 15, 2023 11:27 ET

PainReform (PRFX) Gets a Buy From Maxim Group

TipRanksAug 17, 2022 09:10 ET